At a recent client event in Guaratingueta, Sao Paulo, BASF SE's BASFY Monomers division announced that it has increased the manufacturing capacity for sodium methylate. During the second quarter, the company raised the nameplate capacity of its sodium methylate plant in Guaratingueta, Brazil, to 90,000 metric tons per year. This capacity increase is another step in BASF's business expansion for sodium methylate in South America, demonstrating the company's commitment to its customers and the South American biodiesel market. In addition to the sodium methylate facility, the site houses 12 other production facilities that produce more than 1,500 solutions and products, including crop protection, adhesives, resins, paints, detergents, cosmetics and automotive market solutions. Brazil is among the global leaders in the use and manufacturing of biofuels, such as biodiesel. Its growth has been aided by established legislation requiring a percentage of biodiesel to be mixed with petroleum diesel, not only promoting productivity and sustainability in heavy duty transportation but also assisting various regions in creating more economic opportunities for local citizens. Sodium methylate is an effective and dependable catalyst that offers a more sustainable solution for the production and use of biodiesel, meeting engine manufacturers' demands for high-quality fuels and fewer emissions. Sodium methylate promotes higher yields and lower production costs for biodiesel. Shares of BASFY have lost 1.7% over the past year against a 10.8% decline of its industry. Zacks Investment Research Image Source: Zacks Investment Research Zacks Rank & Key Picks BASF currently carries a Zacks Rank #4 (Sell). Better-ranked stocks in the basic materials space include Carpenter Technology Corporation CRS, Ecolab Inc. ECL and Kronos Worldwide, Inc. KRO. Carpenter Technology currently carries a Zacks Rank #1 (Strong Buy). CRS beat the Zacks Consensus Estimate in each of the last four quarters, with the average earnings surprise being 15.1%. The company's shares have soared 93.2% in the past year. You can see the complete list of today's Zacks #1 Rank stocks here. The Zacks Consensus Estimate for Ecolab's current-year earnings is pegged at $6.59 per share, indicating a year-over-year rise of 26.5%. The Zacks Consensus Estimate for ECL's current-year earnings has been going up in the past 30 days. ECL, a Zacks Rank #2 (Buy) stock, beat the consensus estimate in each of the last four quarters, with the average earnings surprise being 1.3%. The company's shares have rallied roughly 32.3% in the past year. Kronos Worldwide currently carries a Zacks Rank #2. KRO has a projected earnings growth rate of 297.7% for the current year. The company’s shares have rallied around 42% in the past year. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Ecolab Inc. (ECL):Free Stock Analysis Report BASF SE (BASFY):Free Stock Analysis Report Carpenter Technology Corporation (CRS):Free Stock Analysis Report Kronos Worldwide Inc (KRO):Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
BASF (BASFY) Expands Sodium Methylate Capacity in South America
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...